Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In addition, revealed significant alterations in both steroid biosynthesis and arginine-proline metabolism modules, characterized by markedly reduced levels of 25(OH)D3, Calcidiol, and Pregnanediol.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
According to the Modified Quantitative Subjective Global Assessment (MQSGA) scores combined with clinical biochemical indicators, the MHD patients were divided into three groups: the well nourished group (Group A), the mild to moderate malnutrition group (Group B), and the severe malnutrition group (Group C).
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
Study design awaiting verification · Frontiers in Physiology · 2026
Original publication title
Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
Copyright © 2026 Shi, Wang, Zhang, Du, Luo, Xu, Xie, Cao and Cao.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Malnutrition is a common and serious complication in maintenance hemodialysis (MHD) patients, significantly impacting their prognosis. However, the metabolic characteristics and diagnostic biomarkers of the nutritional status of MHD patients remain inadequately explored.
Source: ObjectiveAbstract: What methods does the paper describe?
We compared the clinical baseline characteristics between 100 MHD patients and 60 healthy controls. According to the Modified Quantitative Subjective Global Assessment (MQSGA) scores combined with clinical biochemical indicators, the MHD patients were divided into three groups: the well nourished group (Group A), the mild to moderate malnutrition group (Group B), and the severe malnutrition group (Group C). We then analyzed the differences in MQSGA scores and clinical characteristics among these three groups. Untargeted plasma metabolomics profiles were analyzed to identify differential metabolites and dysregulated metabolic pathways.
Additionally, weighted gene co-expression network analysis (WGCNA) was employed in this study to screen key metabolic modules and potential biomarkers associated with malnutrition in MHD patients. Finally, the sensitivity and specificity of the core metabolites were evaluated using receiver operating characteristic (ROC) curves, and the reliability of candidate metabolite results was validated by colorimetric methods.
Source: MethodsAbstract: Results
Clinical data results showed that compared with normal population, the MHD patient group exhibited decreased expression of nutritional indicators (BMI, Alb, PA, Hb) and bone metabolism-related indicators (Ca, VitD, Klotho). Furthermore, as the severity of malnutrition increased, the levels of these indicators gradually decreased. Conversely, the levels of Scr, BUN, P, CRP, iPTH, and FGF-23 gradually increased. Metabolomics results identified multiple differential metabolites among the three groups, and KEGG analysis revealed enrichment in steroid biosynthesis and the arginine-proline pathway. In addition, revealed significant alterations in both steroid biosynthesis and arginine-proline metabolism modules, characterized by markedly reduced levels of 25(OH)D3, Calcidiol, and Pregnanediol.
Conversely, the concentrations of L-glutamate and trans-4-hydroxy-L-proline were significantly elevated (P < 0.05). Moreover, the results of ROC curve analysis combined with validation tests indicate that the above five metabolites may have good diagnostic performance for MHD patients with malnutrition (P < 0.05).
Source: ResultsAbstract: Conclusion
Our findings highlight the metabolic derangements underlying malnutrition in MHD patients and propose novel biomarkers for early diagnosis. These insights may facilitate targeted interventions to improve clinical outcomes.
Source: ConclusionAuthors’ abstract
Objective
Malnutrition is a common and serious complication in maintenance hemodialysis (MHD) patients, significantly impacting their prognosis. However, the metabolic characteristics and diagnostic biomarkers of the nutritional status of MHD patients remain inadequately explored.
Methods
We compared the clinical baseline characteristics between 100 MHD patients and 60 healthy controls. According to the Modified Quantitative Subjective Global Assessment (MQSGA) scores combined with clinical biochemical indicators, the MHD patients were divided into three groups: the well nourished group (Group A), the mild to moderate malnutrition group (Group B), and the severe malnutrition group (Group C). We then analyzed the differences in MQSGA scores and clinical characteristics among these three groups. Untargeted plasma metabolomics profiles were analyzed to identify differential metabolites and dysregulated metabolic pathways.
Additionally, weighted gene co-expression network analysis (WGCNA) was employed in this study to screen key metabolic modules and potential biomarkers associated with malnutrition in MHD patients. Finally, the sensitivity and specificity of the core metabolites were evaluated using receiver operating characteristic (ROC) curves, and the reliability of candidate metabolite results was validated by colorimetric methods.
Results
Clinical data results showed that compared with normal population, the MHD patient group exhibited decreased expression of nutritional indicators (BMI, Alb, PA, Hb) and bone metabolism-related indicators (Ca, VitD, Klotho). Furthermore, as the severity of malnutrition increased, the levels of these indicators gradually decreased. Conversely, the levels of Scr, BUN, P, CRP, iPTH, and FGF-23 gradually increased. Metabolomics results identified multiple differential metabolites among the three groups, and KEGG analysis revealed enrichment in steroid biosynthesis and the arginine-proline pathway. In addition, revealed significant alterations in both steroid biosynthesis and arginine-proline metabolism modules, characterized by markedly reduced levels of 25(OH)D3, Calcidiol, and Pregnanediol.
Conversely, the concentrations of L-glutamate and trans-4-hydroxy-L-proline were significantly elevated (P < 0.05). Moreover, the results of ROC curve analysis combined with validation tests indicate that the above five metabolites may have good diagnostic performance for MHD patients with malnutrition (P < 0.05).
Conclusion
Our findings highlight the metabolic derangements underlying malnutrition in MHD patients and propose novel biomarkers for early diagnosis. These insights may facilitate targeted interventions to improve clinical outcomes.
Publication and source details
Original title: Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
Bin Shi; Xuyan Wang; Jingya Zhang; Liang Du; Hongyan Luo; Haixin Xu; Jing Xie; Jia Cao; Li Cao
Frontiers in Physiology · 2026
* Correspondence: Li Cao, nxcaoli@163.com; Jia Cao, caojiamed@126.com†These authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:28:01.926380+00:00
DOI: 10.3389/fphys.2026.1822660 · PMC13710070